VENTUS MEDICAL LIMITED

Ventus Medical Limited is a research‑and‑development company dedicated to creating safer, more effective nicotine‑delivery solutions. Drawing on decades of expertise in the nicotine and pharmaceutical sectors, the team is pioneering disruptive technology that aims to curb tobacco‑related harm and, ultimately, save millions of lives – the single most preventable cause of premature death worldwide.

The company’s flagship product, ENHALE, represents a breakthrough in licensed medicine, currently undergoing regulatory review in the United Kingdom with a European assessment slated to follow. By exceeding regulatory standards and integrating patient insights, Ventus Medical is positioning ENHALE as a credible, health‑focused alternative to traditional tobacco products.

Ventus Medical’s mission is rooted in public‑health ambition: to provide smokers with a safer nicotine option that aligns with the World Health Organisation’s vision of tobacco‑smoke‑free air for all. Their collaborative, science‑driven approach makes them a trusted partner for regulators, healthcare professionals and anyone seeking a smoke‑free future.